Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.1% | −1.4% | +4.5% | +5.8% | +45.7% | +53.0% | +170.1% | +32.8% | +1,493.0% |
| Peer average | −2.9% | +1.5% | −20.0% | −26.5% | −8.5% | −10.0% | +88.4% | +37.8% | — |
| S&P 500 · VOO | −0.4% | +2.6% | −2.3% | −2.1% | +11.5% | +11.6% | +79.3% | +72.7% | — |
$165 of every $1,000 in BIB is Proshares
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | —Net Other Assets (Liabilities) | — | 20.46% | $2,045.62 | 21.1M | $21.1M |
| 2 | IQMMProshares Genius MNY MKT ETF | Financial Services | 16.47% | $1,647.28 | 170K | $17.0M |
| 3 | GILDGilead Sciences | Healthcare | 5.70% | $569.84 | 35K | $5.9M |
| 4 | AMGNAmgen | Healthcare | 5.39% | $539.47 | 12K | $5.6M |
| 5 | VRTXVertex Pharmaceuticals | Healthcare | 4.95% | $494.75 | 9,419 | $5.1M |
| 6 | REGNRegeneron Pharmaceuticals | Healthcare | 3.91% | $390.96 | 4,246 | $4.0M |
| 7 | MRNAModerna | Healthcare | 3.75% | $375.39 | 17K | $3.9M |
| 8 | RVMDRevolution Medicines | Healthcare | 1.54% | $153.62 | 8,999 | $1.6M |
| 9 | BIIBBiogen | Healthcare | 1.50% | $150.43 | 6,204 | $1.6M |
| 10 | ILMNIllumina | Healthcare | 1.29% | $128.61 | 6,340 | $1.3M |
| 11 | RPRXRoyalty Pharma | Healthcare | 1.24% | $124.38 | 19K | $1.3M |
| 12 | ROIVRoivant Sciences | Healthcare | 1.17% | $117.40 | 30K | $1.2M |
| 13 | ARGXArgenx SE | Healthcare | 1.09% | $108.86 | 1,146 | $1.1M |
| 14 | INSMInsmed | Healthcare | 1.05% | $104.78 | 9,168 | $1.1M |
| 15 | UTHRUnited Therapeutics | Healthcare | 1.03% | $103.50 | 1,802 | $1.1M |
of the $126B in 408 An index ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | IQMM | Proshares Genius MNY MKT ETF | 16.47% |
| 2 | GILD | Gilead Sciences | 5.70% |
| 3 | AMGN | Amgen | 5.39% |
| 4 | VRTX | Vertex Pharmaceuticals | 4.95% |
| 5 | REGN | Regeneron Pharmaceuticals | 3.91% |
| 6 | MRNA | Moderna | 3.75% |
| 7 | RVMD | Revolution Medicines | 1.54% |
| 8 | BIIB | Biogen | 1.50% |
| 9 | ILMN | Illumina | 1.29% |
| 10 | RPRX | Royalty Pharma - | 1.24% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 23, 2026 | Sep 29, 2026 | $0.0826 |
| Mar 25, 2026 | Mar 31, 2026 | $0.0071 |
| Dec 24, 2025 | Dec 31, 2025 | $0.13 |
| Sep 24, 2025 | Sep 30, 2025 | $0.18 |
| Jun 25, 2025 | Jul 1, 2025 | $0.17 |
| Mar 26, 2025 | Apr 1, 2025 | $0.13 |
| Dec 23, 2024 | Dec 31, 2024 | $0.40 |
| Sep 25, 2024 | Oct 2, 2024 | $0.15 |
| Jun 26, 2024 | Jul 3, 2024 | $0.26 |
| Mar 20, 2024 | Mar 27, 2024 | $0.0403 |
| Dec 20, 2023 | Dec 28, 2023 | $0.0384 |
| Dec 22, 2022 | Dec 30, 2022 | $0.0199 |